Curiox Biosystems Co., Ltd. Disclosures

445680 · KOSDAQ · Based on DART filings

Disclosures

1 major

Newest first

Oct 27, 2026 5:49 PMMajor

20261027900676

Curiox Biosystems' Q3 2026 consolidated revenue was KRW 1,492 million, up 7.73% year over year and 26.87% quarter over quarter, with an operating loss of KRW 3,960 million.

Catch the next disclosure fast

Get app alerts for new disclosures from Curiox Biosystems Co., Ltd..